Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
ASSETS
Cash and cash equivalents	$ 40,916	$ 11,773
Restricted cash	2,566	1,010
Accounts receivable	2,087	2,494
Note receivable	2,552	0
Due from related parties	13,124	2,667
Investment in unconsolidated subsidiaries	1,803	2,158
Prepaid expense and other assets	4,759	3,368
Property and equipment, net	981	1,124
Right-of-use assets	14,789	6,491
Deferred tax assets, net	45,151	37,621
Intangibles, net	128,788	143,738
Goodwill	418,701	369,982
Total assets	676,217	582,426
LIABILITIES:
Accounts payable	401	1,103
Accrued expenses	12,474	11,912
Due to related parties	2,258	2,200
Other liabilities	1,808	254
Contingent consideration	22,963	593
Deferred revenues	12,953	10,347
Lease liabilities	15,700	7,682
Debt obligations	212,496	290,055
Total liabilities	281,053	324,146
COMMITMENTS AND CONTINGENCIES (NOTE 13)
REDEEMABLE NONCONTROLLING INTEREST	0	198,439
STOCKHOLDERS' EQUITY:
Common stock - $0.001 par value; shares authorized, and issued and outstanding, respectively		63
Treasury stock	(273)	(273)
Additional paid-in-capital	650,405	324,310
Accumulated deficit	(255,085)	(264,259)
Total stockholders' equity	395,164	59,841
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	676,217	$ 582,426
Class A Common Stock
STOCKHOLDERS' EQUITY:
Common stock - $0.001 par value; shares authorized, and issued and outstanding, respectively	34
Class B Common Stock
STOCKHOLDERS' EQUITY:
Common stock - $0.001 par value; shares authorized, and issued and outstanding, respectively	$ 83